Digital Content 
NEWS #PharmaBuzz
24 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/inhibrx-biosciences-reports-positive-topline-results-from-its-registrational-trial-of-ozekibart-inbrx-109-in-chondrosarcoma-and-provides-updates-on-colorectal-cancer-and-ewing-sarcoma-expansion-cohorts-302593250.html
23 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251023640173/en/Nuvation-Bio-Enrolls-First-Patient-in-Global-Randomized-Study-of-Safusidenib-for-Maintenance-Treatment-of-High-Grade-IDH1-Mutant-Glioma
08 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/08/3146057/0/en/NeuroNOS-Granted-FDA-Orphan-Drug-Designation-for-Glioblastoma-the-Most-Common-and-Deadliest-Primary-Malignant-Brain-Cancer-in-Adults.html
12 May 2025
// FDA
06 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/06/3038114/0/en/Allarity-Therapeutics-Announces-Phase-2-Trial-of-Stenoparib-in-Combination-with-Temozolomide-for-Recurrent-Small-Cell-Lung-Cancer-Fully-Funded-by-the-US-Veterans-Administration.html
14 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nanopharmaceutics-and-northwestern-university-announce-initiation-of-phase-i-adaptive-dose-escalation-clinical-study-with-dose-expansion-of-oral-triapine-in-combination-with-temozolomide-tmz-for-patients-with-recurrent-glioblas-302145367.html
Share 